Drug intelligence / Profile preview

metenolone enanthate

Development stage
Discontinued
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Metenolone enanthate is a long-acting injectable anabolic-androgenic steroid (AAS) and a derivative of dihydrotestosterone (DHT). It is the 17β-enanthate ester of metenolone, which serves as a prodrug that allows for a slow release of the active hormone from the injection site. The drug acts as an agonist of the androgen receptor, promoting anabolic effects such as nitrogen retention and protein synthesis while exhibiting relatively low androgenic potency compared to testosterone. Historically developed by Schering, it was used clinically to treat conditions such as anemia, breast cancer, and muscle wasting syndromes associated with surgery, infection, or trauma. Although it has been discontinued in several major markets, including the United States, it remains available in some regions and is frequently used off-label for performance enhancement and bodybuilding. Sinofuture Pharma is identified as a manufacturer of the steroid API.

Brand names
Primobolan DepotNibal Injection
Other names
methenolone enanthatemethenolone heptanoate17beta-hydroxy-1-methyl-5alpha-androst-1-en-3-one 17beta-enanthate
02

Targets

SHBG (Sex hormone-binding globulin)AR (Adrenergic receptors)

Beyond the preview

Go deeper on metenolone enanthate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metenolone enanthate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call